loading

Reviva Pharmaceuticals Holdings Inc Borsa (RVPH) Ultime notizie

pulisher
Feb 18, 2025

Reviva Pharmaceuticals adjusts executive pay, grants stock options By Investing.com - Investing.com South Africa

Feb 18, 2025
pulisher
Feb 18, 2025

Reviva Pharmaceuticals adjusts executive pay, grants stock options - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

Reviva Pharmaceuticals Approves Executive Compensation Changes - TipRanks

Feb 18, 2025
pulisher
Feb 12, 2025

Unusually active option classes on open February 12th - TipRanks

Feb 12, 2025
pulisher
Feb 10, 2025

Get in on Reviva Pharmaceuticals Holdings Inc’s (RVPH) buy-in window today! - SETE News

Feb 10, 2025
pulisher
Feb 08, 2025

Analysts Set Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) PT at $11.40 - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

Adversity is less terrifying than hope: Reviva Pharmaceuticals Holdings Inc (RVPH) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Receives Average Recommendation of “Buy” from Analysts - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

How should investors view Reviva Pharmaceuticals Holdings Inc (RVPH)? - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Reviva Pharmaceuticals Holdings Inc (RVPH) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Reviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

Reviva Pharmaceuticals to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 - Nasdaq

Feb 04, 2025
pulisher
Feb 04, 2025

Reviva CEO to Showcase CNS Pipeline at Major Healthcare Conference - StockTitan

Feb 04, 2025
pulisher
Feb 02, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Sees Significant Decline in Short Interest - MarketBeat

Feb 02, 2025
pulisher
Jan 31, 2025

Reviva to Participate in the 2025 BIO CEO & Investor Conference - GlobeNewswire

Jan 31, 2025
pulisher
Jan 30, 2025

Reviva to Participate in the 2025 BIO CEO & Investor Conference -January 30, 2025 at 08:01 am EST - Marketscreener.com

Jan 30, 2025
pulisher
Jan 30, 2025

Reviva CEO Reveals Next-Gen Mental Health Drug Strategy at Major Biotech Summit - StockTitan

Jan 30, 2025
pulisher
Jan 29, 2025

Is Reviva Pharmaceuticals Holdings Inc (RVPH) positioned for future growth? - SETE News

Jan 29, 2025
pulisher
Jan 29, 2025

Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R) - ACCESS Newswire

Jan 29, 2025
pulisher
Jan 25, 2025

HC Wainwright Has Positive Outlook for RVPH FY2024 Earnings - Defense World

Jan 25, 2025
pulisher
Jan 25, 2025

HC Wainwright Has Bullish Outlook for RVPH FY2024 Earnings - MarketBeat

Jan 25, 2025
pulisher
Jan 22, 2025

5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Jan 22, 2025
pulisher
Jan 22, 2025

HC Wainwright Issues Pessimistic Forecast for Reviva Pharmaceuticals (NASDAQ:RVPH) Stock Price - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Receives “Buy” Rating from D. Boral Capital - Defense World

Jan 22, 2025
pulisher
Jan 22, 2025

Reviva Pharmaceuticals' (RVPH) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Reviva Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:RVPH) - MarketBeat

Jan 22, 2025
pulisher
Jan 22, 2025

Reviva Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RVPH) - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

Reviva Pharmaceuticals Unusual Options Activity - Benzinga

Jan 21, 2025
pulisher
Jan 21, 2025

Stock Traders Purchase Large Volume of Reviva Pharmaceuticals Call Options (NASDAQ:RVPH) - MarketBeat

Jan 21, 2025
pulisher
Jan 21, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Given Buy Rating at D. Boral Capital - MarketBeat

Jan 21, 2025
pulisher
Jan 14, 2025

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Short Interest Down 35.9% in December - MarketBeat

Jan 14, 2025
pulisher
Jan 14, 2025

Brokerages Set Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) PT at $11.25 - Defense World

Jan 14, 2025
pulisher
Jan 13, 2025

Geode Capital Management LLC Buys 42,376 Shares of Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) - Defense World

Jan 13, 2025
pulisher
Jan 12, 2025

Reviva Pharmaceuticals stock rated buy by Roth/MKM, backed by Phase 3 results - Investing.com Nigeria

Jan 12, 2025
pulisher
Jan 12, 2025

Roth Mkm Begins Coverage on Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Raised to Buy at Maxim Group - Defense World

Jan 12, 2025
pulisher
Jan 12, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Raised to “Strong-Buy” at Roth Capital - Defense World

Jan 12, 2025
pulisher
Jan 11, 2025

Maxim Group raises Reviva stock to Buy, sets new target By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Analysts Set Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Target Price at $11.25 - MarketBeat

Jan 11, 2025
pulisher
Jan 11, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Upgraded at Roth Capital - MarketBeat

Jan 11, 2025
pulisher
Jan 10, 2025

Maxim Group Upgrades Reviva Pharmaceuticals (NASDAQ:RVPH) to Buy - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Roth MKM Initiates Coverage of Reviva Pharmaceuticals Holdings (RVPH) with Buy Recommendation - MSN

Jan 10, 2025
pulisher
Jan 10, 2025

Maxim Group raises Reviva stock to Buy, sets new target - Investing.com

Jan 10, 2025
pulisher
Jan 10, 2025

Reviva Pharmaceuticals (NASDAQ:RVPH) Coverage Initiated at Roth Mkm - MarketBeat

Jan 10, 2025
pulisher
Jan 07, 2025

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit -January 07, 2025 at 08:02 am EST - Marketscreener.com

Jan 07, 2025
pulisher
Jan 07, 2025

Reviva to Participate in the Lytham Partners 2025 Investor Healthcare Summit - GlobeNewswire

Jan 07, 2025
pulisher
Jan 07, 2025

Reviva Pharmaceuticals CEO to Present at Lytham Partners Healthcare Summit 2025 - StockTitan

Jan 07, 2025
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
Capitalizzazione:     |  Volume (24 ore):